Biopolymer Engineering Scientific Advisory Board
EAGAN, MN – November 23, 2004 – Jonathan S. Reichner, Ph.D., an
Associate Professor in the Department of Surgery at the Brown
University Medical School, Providence, RI, has joined the Scientific
Advisory Board of Biopolymer Engineering, Inc.
Dr. Reichner has conducted extensive research with Biopolymer
Engineering's intravenous beta 1,3/1,6 glucan in wound healing and
infectious disease models. His focus is intracellular signaling
pathways that cause innate immune cells called neutrophils to
initiate a series of host defenses (including chemotaxis,
phagocytosis and oxidative burst) to protect the body. For more
about Dr. Reichner’s research, visit
http://bms.brown.edu/surgery/pages/research.html.
Neutrophils recognize beta 1,3/1,6 glucan, chains of glucose
molecules that are found in the cell walls of yeast, fungi and
bacteria, as foreign. This recognition primes these immune cells to
both bind to infectious microorganisms and navigate to the site of a
wound or infection.
“Through his research, Dr. Reichner has made important contributions
to understanding of how immune cells defend the body,” said Richard
Mueller, Biopolymer Engineering President and Chief Executive
Officer. “His knowledge and insight will be invaluable in efforts to
develop our compounds for pharmaceutical and other uses.”
Dr. Reichner received his Ph.D. in Microbiology and Immunology from
the State University of New York at Buffalo. He completed
postdoctoral work at MD Anderson Hospital & Tumor Institute of the
University of Texas Cancer Center and the Johns Hopkins School of
Medicine.
About Biopolymer Engineering, Inc.
Biopolymer Engineering, Inc. is pioneering carbohydrate
biotechnology to develop proprietary compounds that enhance the
immune system and provide the opportunity to improve global health.
Based in Eagan, Minnesota, the company has 42 U.S. patents
and patents pending, with additional filings in more than 20
countries that protect its products and compounds. Biopolymer
Engineering is developing applications for pharmaceuticals,
nutritional supplements, functional foods, cosmetics and animal feed
and nutrition. Website:
www.biopolymer.com.
Contact:
David Walsh
Biopolymer Engineering, Inc.
651-256-4606
